What question did this study set out to answer?

This study aims to understand treatment delays in HPV-negative oropharyngeal cancer patients by assessing sociodemographic influences.

March 26, 2026Open Access

Characterizing Treatment Delays in Patients With HPV ‐Negative Oropharyngeal Cancer

Key Points

This study aims to understand treatment delays in HPV-negative oropharyngeal cancer patients by assessing sociodemographic influences.
Retrospective chart review of HPV-negative OPSCC patients from 2013 to 2023.
Patients grouped by time to treatment initiation (TTI) based on the median (53.5 days).
Descriptive statistics and Mann–Whitney U tests compared clinical timelines.
Multivariate logistic regression identified predictors of delayed TTI.
Seventy-six patients were reviewed and analyzed for treatment timelines.
Male sex and unmarried status significantly associated with delayed treatment initiation.
Primary treatment type (chemoradiation vs. surgery) impacted TTI significantly.
Intervals from biopsy to referral and PET scan to treatment initiation were longer in delayed patients.

Abstract

ABSTRACT Background Although the impact of increased time to treatment initiation (TTI) on outcomes for patients with oropharyngeal squamous cell carcinoma (OPSCC) has been well‐studied, a deeper understanding of the mechanisms underlying delay in patients with human papillomavirus (HPV)‐negative OPSCC is lacking in the current literature. Objective To assess differences in sociodemographic factors and treatment timelines between patients with HPV‐negative OPSCC with shorter versus. longer TTI. Methods Patients treated for HPV‐negative OPSCC at a single academic institution between 2013 and 2023 were retrospectively identified via chart review and dichotomized by the cohort median TTI (53.5 days; defined as the time from biopsy to first treatment initiation). Clinical timelines between delayed and nondelayed patients were compared using descriptive statistics and Mann–Whitney U testing. Independent predictors of delayed TTI (> 53.5 days) were evaluated using multivariate logistic regression modeling, with adjusted odds ratios (aORs) and 95% confidence intervals reported. Results Seventy‐six patients were identified. On multivariable analysis, male sex (aOR 3.28; 95% CI 1.02–10.49), unmarried status (aOR 5.96; 95% CI 1.36–26.07), primary chemoradiation versus surgery (aOR 0.25; 95% CI 0.07–0.85), and biopsy available before arrival (aOR 4.08; 95% CI 1.32–17.36) were independently and significantly ( p < 0.05) associated with delayed treatment initiation. Treatment timeline analysis revealed that both the interval from biopsy to referral and the interval from PET scan to treatment initiation differed significantly between delayed and nondelayed patients ( p < 0.05). Conclusion Primary nonsurgical treatment and lack of social support were found to be independently associated with treatment delay in patients with HPV‐negative OPSCC. These findings highlight opportunities for improving the care of HPV‐negative OPSCC at the specialty level.

Read Full Paperexternally

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Pauley et al. (Sun,) studied this question.

synapsesocial.com/papers/69c4cd05fdc3bde448918cb8 https://doi.org/https://doi.org/10.1002/cam4.71748

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark

View Full Paper